Cardiovascular Disease and COVID-19

Helpful information sources on COVID-19:

COVID-19

• Latest COVID-19 Information from the US Centers for Disease Control
• US FDA Coronavirus Disease 2019 (COVID-19) Information
• World Health Organization (WHO) Coronavirus disease (COVID-2019) situation reports
• WHO Training on COVID-19

Publications and Podcasts

• 15 Jul 21 PLOS, Daniels, et. al. “Relation of prior statin and anti-hypertensive use to severity of disease among patients hospitalized with COVID-19: Findings from the American Heart Association’s COVID-19 Cardiovascular Disease Registry”
• 30 Mar 21 SciRep, Masana, et. al. “Low HDL and high triglycerides predict COVID-19 severity”
• 05 Mar 21 JTT, Giannis, et. al. “Incidence of Venous Thromboembolism and Mortality in Patients with Initial Presentation of COVID-19”
• 26 Feb 21 NatCom, Gupta, et. al. “Association between antecedent statin use and decreased mortality in hospitalized patients with COVID-19”
• 11 Feb 21 PLOS, Osborne, et. al. “Association of mortality and aspirin prescription for COVID-19 patients at the Veterans Health Administration”
• Jan 21 IFC, Spaccarotella, et. al. “The therapy with RAS inhibitors during the COVID19 pandemic”
• 15 Jan 21 BMJ PMJ, Pal, et. al. “Statin use and clinical outcomes in patients with COVID-19 An updated systematic review and meta-analysis“
• 29 Oct 20 CDisc, Yan, et. al. “Antihypertensive drugs are associated with reduced fatal outcomes and improved clinical characteristics in elderly COVID-19 patients”
• 27 Oct 20 JACC, Mechanick, et. al. “Coronavirus and Cardiometabolic Syndrome JACC Focus Seminar”
• 21 Oct 20 IARS, Chow, et. al. “Aspirin Use is Associated with Decreased Mechanical Ventilation, ICU Admission, and In-Hospital Mortality in Hospitalized Patients with COVID-19“
• 24 Aug 20 CAR, Baral, et. al. “Effect of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with COVID-19: a Systematic Review and Meta-analysis of 28,872 Patients“
• 28 Jul 20 IJM, Alegbeleye, et. al. “The Novel Aspirin as Breakthrough Drug for COVID-19 A Narrative Review“
• 27 Jul 20 Clin and Exp Med, Gavriatopoulou, et al. “Organ-specific manifestations of COVID-19 infection“
• 17 Jul 20 MMWR, Wortham, et. al. “Characteristics of Persons Who Died with COVID19 United States February 12 to May 18 2020” (On July 10, 2020, this report was posted online as an MMWR Early Release. Please note: This report has been corrected.)
• 13 Jul 20 BMJ, Heart Hippisley-Cox, et. al. “Risk of sever COVID-19 disease with ACE inhibitors and angiotensin receptor blockers Cohort study including 8.3 million people“
• 15 Jun 20 Lancet, Clark, et. al. “Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study“
• 15 Jun 20 MMWR, Stokes, et. al. “Coronavirus Disease 2019 Case Surveillance — United States, January 22–May 30, 2020
• 1 May 20 NEJM, Mehra, et. al. “Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19“
• 22 Apr 20 JAMA, Richardson, et. al. “Presenting Characteristics Comorbidities and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area”
• 6 Apr 20 JAMA, Garcelli, et. al. ”Baseline Characteristics and Outcomes of 1591 Patients infected with SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy” (note Table 1)
• 26 Mar 20 Imperial College London, Walker et. al. “The Global Impact of COVID-19 and Strategies for Mitigation and Suppression“
• 20 Mar 20 BMJ, Heart, Podcast “COVID-19 in Seattle – hope for the best, prepare for the worst“
• 18 Mar 20 EHJ, Xiong, et. al. “Coronaviruses and the cardiovascular system“
• 17 Mar 20 JACC, Driggin, et. al. “Cardiovascular Considerations…During the Pandemic“
• 17 Mar 20 Italian Dept of Health “Characteristics of Deceased and Positive COVID-19 Patients in Italy“
• 16 Mar 20 JAMA, Hopman, et. al. “Managing COVID-19 in Low and Middle Income Countries“
• 13 Mar 20 ACC “Heart Patients Warned of Risks from Coronavirus“
• 12 Mar 20 IJID, Yang, et. al. “Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection“
• 9 Mar 20 Lancet, Zhou, et. al. “Clinical course and risk factors for mortality of adult inpatients with COVID-19…“
• 24 Jan 20 Lancet, Huang, et. al. “Clinical features of patients infected with 2019 novel coronavirus“